Wang Y - Search Results

1

Design of ruthenium-albumin hydrogel for cancer therapeutics and luminescent imaging.

Zhao Z, Hu R, Shi H, Wang Y, Ji L, Zhang P, Zhang Q. Zhao Z, et al. Among authors: wang y. J Inorg Biochem. 2019 May;194:19-25. doi: 10.1016/j.jinorgbio.2019.02.002. Epub 2019 Feb 10. J Inorg Biochem. 2019. PMID: 30798078

2

Self-activating nuclease and anticancer activities of copper(II) complexes with aryl-modified 2,6-di(thiazol-2-yl)pyridine.

Li L, Du K, Wang Y, Jia H, Hou X, Chao H, Ji L. Li L, et al. Among authors: wang y. Dalton Trans. 2013 Aug 28;42(32):11576-88. doi: 10.1039/c3dt50395j. Epub 2013 Jul 10. Dalton Trans. 2013. PMID: 23843095

3

Cu(II) inhibits hIAPP fibrillation and promotes hIAPP-induced beta cell apoptosis through induction of ROS-mediated mitochondrial dysfunction.

Ma L, Li X, Wang Y, Zheng W, Chen T. Ma L, et al. Among authors: wang y. J Inorg Biochem. 2014 Nov;140:143-52. doi: 10.1016/j.jinorgbio.2014.07.002. Epub 2014 Jul 15. J Inorg Biochem. 2014. PMID: 25108186

4

Synthesis, DNA interaction and anticancer activity of copper(II) complexes with 4'-phenyl-2,2':6',2″-terpyridine derivatives.

Liang JW, Wang Y, Du KJ, Li GY, Guan RL, Ji LN, Chao H. Liang JW, et al. Among authors: wang y. J Inorg Biochem. 2014 Dec;141:17-27. doi: 10.1016/j.jinorgbio.2014.08.006. Epub 2014 Aug 19. J Inorg Biochem. 2014. PMID: 25172994

5

Dual inhibition of topoisomerases I and IIα by ruthenium(II) complexes containing asymmetric tridentate ligands.

Du K, Liang J, Wang Y, Kou J, Qian C, Ji L, Chao H. Du K, et al. Among authors: wang y. Dalton Trans. 2014 Dec 14;43(46):17303-16. doi: 10.1039/c4dt02142h. Dalton Trans. 2014. PMID: 25315107

6

Ruthenium(II) polypyridyl complexes as dual inhibitors of telomerase and topoisomerase.

Liao G, Chen X, Wu J, Qian C, Wang Y, Ji L, Chao H. Liao G, et al. Among authors: wang y. Dalton Trans. 2015 Sep 14;44(34):15145-56. doi: 10.1039/c4dt03585b. Dalton Trans. 2015. PMID: 25604798

7

Ruthenium nitrosyl functionalized graphene quantum dots as an efficient nanoplatform for NIR-light-controlled and mitochondria-targeted delivery of nitric oxide combined with photothermal therapy.

Guo M, Xiang HJ, Wang Y, Zhang QL, An L, Yang SP, Ma Y, Wang Y, Liu JG. Guo M, et al. Among authors: wang y. Chem Commun (Camb). 2017 Mar 18;53(22):3253-3256. doi: 10.1039/c7cc00670e. Epub 2017 Mar 6. Chem Commun (Camb). 2017. PMID: 28261712

8

A NIR phosphorescent osmium(ii) complex as a lysosome tracking reagent and photodynamic therapeutic agent.

Zhang P, Wang Y, Qiu K, Zhao Z, Hu R, He C, Zhang Q, Chao H. Zhang P, et al. Among authors: wang y. Chem Commun (Camb). 2017 Nov 14;53(91):12341-12344. doi: 10.1039/c7cc07776a. Chem Commun (Camb). 2017. PMID: 29098209

9

Chirality in metal-based anticancer agents.

Wang Y, Huang H, Zhang Q, Zhang P. Wang Y, et al. Dalton Trans. 2018 Mar 28;47(12):4017-4026. doi: 10.1039/c8dt00089a. Epub 2018 Feb 26. Dalton Trans. 2018. PMID: 29479608 Review.

10

A novel iridium(iii) complex for sensitive HSA phosphorescence staining in proteome research.

Wang Y , Huang H , Chen G , Chen H , Xu T , Tang Q , Zhu H , Zhang Q , Zhang P . Wang Y , et al. Chem Commun (Camb). 2018 Mar 27;54(26):3282-3285. doi: 10.1039/c8cc01597j. Chem Commun (Camb). 2018. PMID: 29537015

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

298,853 results

Search Page

Filters